UK Parliament warns 90% of medicines sourced from China/India, supply risk
Published 2 d ago2 sourcesEvidence: Reported
A U.S. security commission warns Beijing is advancing across the entire pharmaceutical supply chain, from raw materials to finished drugs, potentially leaving less self-sufficient countries exposed in the next health emergency. The claim is an assessment based on observed deal-making and industrial policy, not a confirmed event. This matters because it signals growing strategic competition in a critical sector and could prompt allied reshoring or export-control responses.
AI disclosure: Model-written summary of the source, not a verified fact. Check the sources. How Mosaic works
Locations
Entities
A US national security commission claims China is increasing its control over the entire pharmaceutical supply chain, from raw materials to finished drugs, potentially creating national security risks for the US and other less self-sufficient nations. This assessment is based on observed Chinese industrial policy and deal-making, not a confirmed event. The specific scope and nature of proposed new Chinese restrictions remain unclear.
Published 2 d ago2 sourcesEvidence: Reported
Published 2 d ago7 sourcesEvidence: Reported
Published 23 h ago2 sourcesEvidence: Reported
Published 1 d ago1 sourceEvidence: Reported
Published 2 d ago1 sourceEvidence: Reported
Published 2 d ago6 sourcesEvidence: Reported
Published 1 d ago6 sourcesEvidence: Reported
Published 1 d ago7 sourcesEvidence: Reported